QCI Interpret for Oncology

Comprehensive Molecular Tumor Analysis with Alacris Theranostics

March 09, 2023
Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choices. However, deeper molecular insights are needed to improve personalized treatment decisions. Integrating gene expression analysis in personalized oncology provides an additional level of insight. These analyses include evaluating expressed mutations and drug targets, novel gene fusions, clinically relevant signatures, and the tumor immune microenvironment (TME).

Alacris Theranostics developed the Comprehensive Molecular Tumor Analysis (CMTA), a NGS-based tumor diagnostic test. The test integrates whole exome and transcriptomic sequencing (WES and RNAseq). The test deploys as an end-to-end accredited diagnostic platform from tumor sample uptake (FFPE or frozen) to personalized clinical interpretation reports.  CMTA is a tumor-agnostic test that displays a unique molecular view of each sample. CMTA is a useful approach for refractory cancers with complex patterns or tumors of unknown origin.

In this webinar, viewers will:

Learn about the strategy implemented in Alacris’ bioinformatics pipeline to identify cancer-relevant somatic events
Learn how Alacris uses QCI Interpret for Oncology to annotate variants and identify potential therapies
Be eligible for a complimentary QCI Interpret demo and sample report

Related videos

QCI Interpret for Oncology

FASTQ to final report: Ultra-fast workflow for CGP

272 views July 21, 2022

As our molecular knowledge of cancer continually evolves, a new era in cancer...

QCI Interpret for Oncology

50 to 500 genes: Scale-up to comprehensive genomic profiling

133 views July 13, 2022

In this webinar, we present a workflow-agnostic, informatics software...

QCI Interpret for Oncology

Comparison of methods in routine somatic diagnostics

166 views April 12, 2022

Dr. Mattia Schmid from UniLabs, Switzerland compares the methods of molecular...

QCI Interpret for Oncology

Gaining insights with transcriptomic profiling and mechanistic modeling

288 views June 11, 2021

In this webinar, Moritz Schütte, head of next-generation sequencing data...